FormFactor, Inc. (NASDAQ:FORM – Get Free Report) has earned an average recommendation of “Hold” from the eleven analysts that are covering the stock, Marketbeat.com reports. Seven analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $57.00.
FORM has been the topic of a number of recent research reports. Cantor Fitzgerald assumed coverage on FormFactor in a report on Tuesday, November 18th. They issued an “overweight” rating and a $75.00 target price on the stock. Cowen restated a “hold” rating on shares of FormFactor in a research note on Thursday, October 30th. DA Davidson set a $55.00 price objective on shares of FormFactor in a report on Thursday, October 30th. Citigroup upgraded shares of FormFactor from a “neutral” rating to a “buy” rating and increased their target price for the company from $31.00 to $62.00 in a report on Thursday, October 30th. Finally, Stifel Nicolaus set a $42.00 price target on shares of FormFactor in a report on Thursday, October 30th.
Check Out Our Latest Research Report on FORM
Insider Activity at FormFactor
Hedge Funds Weigh In On FormFactor
Several institutional investors have recently added to or reduced their stakes in FORM. GAMMA Investing LLC raised its position in FormFactor by 12.6% in the fourth quarter. GAMMA Investing LLC now owns 5,184 shares of the semiconductor company’s stock worth $289,000 after acquiring an additional 579 shares during the period. CIBC Bancorp USA Inc. bought a new position in shares of FormFactor during the 3rd quarter valued at approximately $303,000. CANADA LIFE ASSURANCE Co increased its stake in shares of FormFactor by 8.8% during the 3rd quarter. CANADA LIFE ASSURANCE Co now owns 94,535 shares of the semiconductor company’s stock worth $3,423,000 after purchasing an additional 7,650 shares during the last quarter. Voleon Capital Management LP bought a new stake in shares of FormFactor in the 3rd quarter worth approximately $935,000. Finally, Voloridge Investment Management LLC raised its holdings in shares of FormFactor by 13.7% in the 3rd quarter. Voloridge Investment Management LLC now owns 388,449 shares of the semiconductor company’s stock worth $14,147,000 after purchasing an additional 46,911 shares during the period. Institutional investors own 98.76% of the company’s stock.
FormFactor Price Performance
Shares of NASDAQ FORM opened at $62.72 on Thursday. The stock has a market cap of $4.86 billion, a price-to-earnings ratio of 120.62 and a beta of 1.12. The company has a debt-to-equity ratio of 0.01, a quick ratio of 3.46 and a current ratio of 4.30. FormFactor has a fifty-two week low of $22.58 and a fifty-two week high of $66.47. The firm’s 50-day simple moving average is $55.42 and its 200 day simple moving average is $41.77.
FormFactor Company Profile
FormFactor, Inc (NASDAQ:FORM) is a leading provider of advanced test and measurement solutions for the semiconductor industry. The company specializes in the design, development and manufacture of high-performance wafer-level and package-level test interfaces used in wafer sort, characterization, reliability and failure analysis applications. By leveraging precision microelectromechanical systems (MEMS) and photolithographic processes, FormFactor delivers probe cards, analytical probes and test sockets that enable device makers to validate next-generation integrated circuits across logic, memory, RF, analog and power applications.
FormFactor’s product portfolio includes custom probe cards for wafer probers, TEM-based analytical probes for material and device characterization, and socket solutions for burn-in and final test of packaged devices.
See Also
- Five stocks we like better than FormFactor
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- YDES Could Be 2026’s Biotech Breakthrough
Receive News & Ratings for FormFactor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FormFactor and related companies with MarketBeat.com's FREE daily email newsletter.
